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Abstract
The effects of aqueous extract of Ocimum gratissimum leaf (AOGL) on the renal function of rats with gentamicin-induced
nephrotoxicity were investigated. This study involved the use of forty five (45) adult male Wistar rats (housed in separate
metabolic cages) such that graded doses of OAGL were administered to the experimental groups (p.o.) for 28 days after exposure
to gentamicin toxicity (100 mg/kg i.p.) for 1 week. At the end of the study, comparisons of some indices of renal function as well as
antioxidant status (GSH and TBARS) were made between the control, toxic and AOGL-treated groups at P < 0.05. The result
showed that gentamicin treatment caused significant increase (P < .05) in urine output, urea, creatinine, total protein, relative
kidney weight, and TBARS, as well as significant decrease (P < .05) in urine creatinine and GSH levels. Post-treatment with graded
doses of AOGL caused significant increase in food consumption, GSH, urine, and plasma creatinine, as well as significant decrease
(P < .05) in relative kidney weight, TBARS, and urine total protein. There was an appreciable difference in the kidney histology of
the AOGL-treated groups when compared with the toxic control. Hence, the extract has therapeutic potential in the man-
agement of gentamicin-induced kidney injury, although a risk profile of renal dysfunction is not unlikely from 28 days of admin-
istration as evident by the decrease in creatinine clearance.
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Nephrotoxicity is an associated limitation for the clinical use of
gentamicin, a potent gram-negative antibiotic.1 Renal injury
following gentamicin administration results from the inhibition
of protein synthesis by renal cells, causing these cells to
become necrotic in the proximal tubules.2 Consequently, renal
inflammation, tubular necrosis, and glomerular damage are the
major events implicated in gentamicin nephrotoxicity.3,4
Ocimum gratissimum, an herbaceous plant belonging to the
Labiatae family, is common in West Africa and India, which
are tropical areas. It is widely cultivated in Nigeria, South Sea
Islands, as well as Deccan and Nepal.5 In Nigeria, this plant is
known by several vernacular names such as “effinrin-nla,”
“Ahuji,” and “Daidoya” by the Yoruba-, Igbo-, and Hausa-
speaking tribes, respectively.6 It has found its relevance in
traditional system of medicine and has been evaluated for its
anti-epilepsy and antidiarrhea properties as well as abating high
fever.6 Because the leaves and flowers of Ocimum gratissimum
are rich in essential oils, which are reputed for their therapeutic
value, this plant is used to prepare traditional tea and infu-
sions.7 Other medicinal values include, but are not limited to,
preparation of decoctions for the treatment of mental illness8 as
well as treatment of fungal infections, cold, and catarrh.9
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Regardless of the apparently vast medicinal properties ofOci-
mum gratissimum, till date, available scientific data are inade-
quate to infer the nephrocurative and or nephrotoxic potentials
of this plant in models of drug-induced kidney injury. Therefore,
this study aimed at contributing to the body of existing knowledge
by studying the effects of 28 days of administration of aqueous
extract of Ocimum gratissimum leaf (AOGL) on the renal func-
tion of Wistar rats with gentamicin-induced kidney injury.
Materials and Methods
Drugs
Gentamicin injection 80 mg/2 mL was purchased from Shanxi Shu-
guang Pharmaceutical Co (Jinzhong, China), while the metabolic cages
used for this study were fabricated by Central Technological Laboratory
and Workshops, Obafemi Awolowo University, Ile-Ife, Nigeria.
Extraction Process
Leaves of Ocimum gratissimum were collected, washed, air dried
under shade, and ground into fine powder using a blender. The aqu-
eous extract was prepared by macerating the powdered leaves (323 g)
with 3 L of distilled water in an electric shaker for 48 hours. The
extract was filtered through Whatmann No. 1 paper (Whatmann
International Ltd, Maidstone, England) and evaporated under reduced
pressure using a rotary evaporator. The yield (33.60 g) was kept in a
bottle with a tight-fitting cover until it was needed for the study.
Extraction yield in % ¼ 33:60=323  100 ¼ 10:4%
Animal Care and Management
Forty-five adult male Wistar rats weighing 150 to 200 g were used for
this study. They were obtained from the Animal Holdings of the
College of Health Sciences, Obafemi Awolowo University, Ile-Ife,
and were housed in plastic cages. The rats were kept under natural
light/dark cycle and had access to standard rodent pellet diet (Caps
Feed PLC, Osogbo, Nigeria) and water ad libitum. They were allowed
to acclimatize in the laboratory for 2 weeks before the commencement
of the study.
Experimental Design
The rats were divided into 5 groups as follows: Group 1 (control)
consisting of 5 rats received 2 mL/kg/day of distilled water via oral
route for the study period. Twenty-four hours after final administra-
tion, the rats were euthanized. Group 2 (toxic) consisted of 10 rats,
each of which received 100 mg/kg/day of gentamicin (intraperitoneal)
for a week and thereafter left untreated (without AOGL) for 4 weeks.
Five rats each were sacrificed a day after the final gentamicin admin-
istration as well as after 14 days of recovery period. Groups 3, 4, and 5
consisted of 10 rats each that were pretreated with gentamicin as group
2 and thereafter received graded doses of AOGL at 100, 200, and
400 mg/kg/day per os, respectively, for 28 days. Five rats from each
group were sacrificed a day after the last dose of AOGL, while the
remaining 5 rats were left for a 14-day recovery period. Creatinine
clearance was calculated for all groups using the conventional formula:
C ¼ U V=P
where C ¼ clearance, U ¼ urine creatinine, V ¼ urine flow rate
(volume of urine/time), and P ¼ plasma creatinine.
Assessment of Body Weight
This was carried out weekly with the aid of a digital weighing scale
(Camry, Zhongshan, China).
Assessment of Food Consumption, Water Intake, and
Urine Volume
This was carried out with the aid of metabolic cages. The food con-
sumption and water intake were determined by taking the difference
between the previous weight/volumes and the leftover food after
24 hours. The value obtained was taken as the daily food consump-
tion/water intake for each rat in the different groups.
The volumes of water taken and urine excreted by each rat were
measured with a measuring cylinder, while food consumption was
measured with the aid of a digital weighing scale (Camry, China).
Biochemical Assay
Blood obtained after the rats were euthanized was collected into
separate ethylenediaminetetraacetic acid bottles and centrifuged
at 4000 rpm for 15 minutes using Cold Centrifuge (Model 8881,
Centurion Scientific, West Sussex, England). The resulting
plasma was analyzed for some biochemical indices of renal func-
tion. The urine samples were similarly subjected to the same
procedure.
Plasma Creatinine and Urea
Using a colorimetric method,10 the plasma creatinine and urea con-
centrations were estimated using the laboratory protocol outlined by
the manual provided in the Randox standard laboratory kit.
Urine Creatinine and Urea
Urine samples were diluted with distilled water using 1 in 50.
Thereafter, 0.1 mL of the diluted urine was pipette into the test
tube for the aforementioned colorimetric method for creatinine and
urea determination.
Protein Determination
Protein determination was carried out according to the method of
Lowry et al11 as described by Holme and Peck.12
Assessment of Antioxidant Status
Each carefully excised left kidney was weighed and homogenized
with 10 mL of sucrose solution (0.25 M) using Electric Homogenizer
(SI601001). The homogenate was centrifuged at 3000 rpm for
20 minutes and the supernatant was collected for the assessment of
reduced glutathione (GSH) as well as thiobarbituric acid reactive
substance (TBARS) levels.
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Estimation of Reduced Glutathione and Thiobarbituric
Acid Reactive Substance (TBARS) in the Kidney
Homogenate
GSH was measured by the method of Beutler et al,13 while TBARS
was determined by the method of Ohkawa et al.14
Histopathological Examination
After rats were sacrificed, their right kidneys were carefully excised,
weighed, and fixed in 10% formo-saline solution. Thereafter, the tis-
sues were embedded in paraffin wax, sectioned, and stained using
hematoxylin and eosin.
Statistical Analysis
The results obtained were expressed as mean + SEM. The data were
analyzed using one-way analysis of variance followed by Neumann-
Keuls post hoc test with the aid of GraphPad prism (GraphPad
Software Inc, La Jolla, CA) statistical package. The results were
considered significant when P < .05.
Results
Food Consumption and Body Weight
Insignificant increase in food consumption and body
weight were observed in the toxic group when compared
with their pretreatment values (Table 1). However, the food
consumption and body weight of the toxic recovery group
increased significantly (P < .05) when compared with both
its pretreatment values and values obtained during genta-
micin administration. The food consumption and body
weight of the AOGL-treated groups and those that were
left for a 2-week recovery period were significantly higher
(P < .05) when compared with their pretreatment values
and values obtained during gentamicin administration
(Table 1).
Water Intake and Urine Volume
A significant increase (P < .05) in urine volume was observed
in the toxic group without a corresponding increase in water
intake when compared with its pretreatment value (Table 2).
Table 1. Effects of Aqueous Extract of Ocimum gratissimum on Food Consumption (g) and Body Weight (g) of Rats with Gentamicin-Induced
Nephrotoxicity.
Control Toxic Toxic Recovery 100 mg/kg AOGL 200 mg/kg AOGL 400 mg/kg AOGL
Food consumption (g)
Baseline 17.60 + 0.96 27.00 + 2.00 14.25 + 0.76 12.25 + 1.65 14.50 + 2.21 15.60 + 1.69
Gentamicin treatment 24.00 + 1.68 33.60 + 5.27 15.50 + 1.55 16.50 + 1.70 17.80 + 2.79 19.00 + 1.29
28 days treatment 23.20 + 0.96 — 28.75 + 1.25*y 30.00 + 0.91*y 34.00 + 3.02*y 34.60 + 2.29*y
14 days recovery 18.20 + 0.66 — — 28.75 + 1.25*y 31.00 + 1.87*y 32.00 + 2.55*y
Body weight (g)
Baseline 204.0 + 3.55 188.0 + 12.41 94.00 + 1.73 98.00 + 3.86 117.4 + 9.05 92.20 + 4.34
Gentamicin treatment 212.6 + 3.89 195.6 + 11.74 103+ 2.12 102.5 + 4.78 122.2 + 8.59 101.80 + 5.29
28 days treatment 239.8 + 5.56*y — 173.3 + 5.39*y 184.0 + 10.46*y 194.2 + 7.55*y 171.0 + 5.16*y
14 days recovery 264.0 + 3.67*y — — 200.0 + 2.25*y 199.0 + 9.67*y 178.0 + 6.04*y
Abbreviation: AOGL, aqueous extract of Ocimum gratissimum leaf.
*Shows significant difference compared to the baseline at P < .05.
yShows significant difference compared to the gentamicin treatment at P < .05.
Table 2. Effects of Aqueous Extract of Ocimum Gratissimum on Water Intake (mL) and Urine Volume (mL) of Rats With Gentamicin-Induced
Nephrotoxicity.
Control Toxic Toxic Recovery 100 mg/kg AOGL 200 mg/kg AOGL 400 mg/kg AOGL
Water intake (mL)
Baseline 31.00 + 2.12 17.40 + 2.16 8.75 + 0.75 9.400 + 0.60 11.20 + 0.97 11.60 + 1.86
Gentamicin treatment 30.60 + 9.51 13.00 + 0.95 13.80 + 1.59 15.00 + 1.92 16.60 + 2.38 23.60 + 2.75
28 days treatment 32.40 + 3.42 — 23.25 + 1.03* 32.67 + 5.60*y 54.80 + 1.07*g 45.75 + 6.27*y
14 days recovery 27.10 + 2.59 — — 12.00 + 1.08 17.75 + 3.22 15.50 + 2.02
Urine volume (mL)
Baseline 9.20 + 1.02 6.00 + 0.89 5.00 + 0.45 3.90 + 0.58 3.90 + 0.43 4.50 + 0.54
Gentamicin treatment 11.30 + 0.95 9.50 + 0.80* 9.75 + 0.82* 7.60 + 0.37* 7.00 + 1.19* 8.10 + 1.22*
28 days treatment 8.30 + 1.55 — 5.12 + 0.42g 5.00 + 1.00 9.00 + 1.52 4.83 + 1.64
14 days recovery 8.12 + 216 — — 7.50 + 0.96* 7.16 + 1.01 4.00 + 0.54
Abbreviation: AOGL, aqueous extract of Ocimum gratissimum leaf.
*Shows significant difference compared to the baseline at P < .05.
yShows significant difference compared to the gentamicin treatment at P < .05.
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However, the water intake of the AOGL-treated groups
increased significantly (P < .05) without a corresponding
increase in urine output when compared with their pretreatment
values. No significant difference was observed in the water
intake and urine volume of rats that were allowed a 2-week
recovery period when compared with their pretreatment values
(Table 2).
Plasma and Urine Level of Creatinine, Urea, and Total
Protein
The plasma creatinine and urea levels of the toxic group were
significantly higher (P < .05) than that of the control group
(Figures 1 and 2). Similarly, the toxic recovery group recorded
a significantly higher (P < .05) plasma creatinine when com-
pared with the control but this was significantly lower when
compared with the toxic group. A significantly higher (P < .05)
plasma creatinine concentration was observed in the
AOGL-treated groups when compared with the control but
no significant difference was shown at the 2-week recovery
period (Figure 1a). The plasma creatinine concentration of
100 mg/kg/day AOGL-treated group was significantly higher
(P < 0.05) than that of the toxic group as well as other treated
groups (Figure 1a).
There was no significant difference observed in the plasma
urea of the AOGL-treated groups when compared with those
Figure 1. Effects of AOGL on plasma and urine creatinine level of Wistar rats with gentamicin-induced nephrotoxicity.
*Shows significant difference compared to the control at P < .05. gShows significant difference compared to the toxic control group at P < .05.
aShows significant difference compared to the toxic recovery group at P < .05.
Figure 2. Effects of AOGL on plasma and urine urea levels of Wistar rats with gentamicin-induced nephrotoxicity.
*Shows significant difference compared to the control at P < .05. gShows significant difference compared to the toxic control group at P < .05.
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that were left for the 2-week recovery period as well as with the
control (Figure 2).
The plasma total protein concentration of the toxic group
and AOGL-treated groups were significantly lower (P < .05)
than that of the control. The plasma total protein concentration
of rats that received 100 mg/kg/day of AOGL were signifi-
cantly higher (P < .05) than that of the toxic group and other
AOGL-treated groups. At 2-week recovery period, the toxic
recovery group had significantly lower (P < .05) plasma total
protein concentration when compared with the control and the
AOGL-treated groups (Figure 3).
The urine creatinine concentration of the toxic group,
AOGL-treated groups, as well as the 2-week recovery groups
were significantly lower (P < .05) when compared with the
control (Figure 1b). The toxic group had significantly higher
urine total protein and urea concentrations when compared
with the control (Figures 3b and 2b, respectively). Urine urea
concentration of the toxic recovery group, AOGL-treated
groups, and 2-week recovery group were significantly higher
(P < .05) when compared with that of the control but was
significantly lower than that of the toxic group (Figure 2b).
However, the urine total protein concentrations of the
AOGL-treated groups and 2-week recovery group showed no
significant difference when compared with the control (Figure
3b). The AOGL-treated groups as well as the 2-week recovery
groups showed a significant decrease (P < 0.05) in urine con-
centrations of urea when compared with that of the toxic con-
trol (Figure 2b).
Relative Kidney Weight, TBARS, and GSH
A significant increase (P <0.05) in the relative kidney weight
was observed in the toxic group when compared with the con-
trol. The relative kidney weight of the toxic recovery group,
AOGL-treated groups, and the 2-week recovery group was not
significantly different from that of the control (Figure 4).
The TBARS level of the toxic group showed a significant
increase (P < 0.05) when compared with the control. The TBARS
levels of the toxic recovery group, AOGL-treated groups, and the
2-week recovery group were significantly lower (P < 0.05) than
that of the toxic group at the end of the study (Figure 5).
The toxic and toxic recovery groups had significantly lower
GSH levels (P < .05) when compared with the control. On the
other hand, the GSH levels of the AOGL-treated groups showed
significant increase (P < .05) in kidney GSH level when
Figure 3. Effects of AOGL on plasma and urine total protein levels of Wistar rats with gentamicin-induced nephrotoxicity.
*Shows significant difference compared to the control at P < .05. gShows significant difference compared to the toxic control group at P < .05.
aShows significant difference compared to the toxic recovery group at P < .05.
Figure 4. Effects of AOGL on relative kidney weight of Wistar rats
with gentamicin-induced nephrotoxicity.
*Shows significant difference compared to the control at P < .05.
gShows significant difference compared to the toxic control group
at P < .05.
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compared with the toxic group. However, at 2 weeks of recovery
period there was no significant difference (P < .05) in GSH
levels of the AOGL-treated groups as well as the toxic recovery
group when compared with the control (Figure 5).
Creatinine Clearance
A significant decrease (P < .05) in creatinine clearance was
observed in the toxic and AOGL-treated groups when com-
pared with the control (Table 3). The creatinine clearance of
the AOGL-treated groups was significantly lower (P < .05)
than that of the toxic group. At the 2-week recovery period,
the toxic recovery group and AOGL-treated groups had signif-
icantly lower (P < .05) creatinine clearance when compared
with the control (Table 3). Also, the AOGL-treated groups
showed a significantly lower (P < .05) creatinine clearance
when compared with the toxic recovery group except for rats
that received 400 mg/kg of AOGL, which showed no signifi-
cant difference from the toxic recovery group (Table 3).
Histopathological Examination
The control group shows evidence of intact renal corpuscles
with normal appearing glomeruli and tubules, including the
proximal convoluted tubule and distal convoluted tubule. There
is, also, evidence of intact Bowman’s space and epithelial lin-
ing of bowman capsule (Figure 6).
The toxic group shows decreased cellularity in the glomer-
uli, loss of cellular constituents of tubules, densely eosinophilic
(colloid) cast in the lumen of some tubules resulting in atrophy,
loss of epithelia cells, as well as severe cloudy swelling/inflam-
mation of the distal convoluted tubules.
Toxic þ recovery group depicts improvement in renal cor-
tex histoarchitecture when compared to toxic. Glomeruli and
surrounding Bowman’s space are mostly intact with no appar-
ent evidence of eosinophilic (“colloid”) casts in the tubular
lumen. Though, there is evidence of slight loss of tubular cel-
lular constituents.
The 100 mg/kg AOGL-treated group shows histological
improvement of the renal cortex. Glomeruli and surround-
ing Bowman’s space are mostly intact. Apparently, no eosi-
nophilic (colloid) casts are observed in the tubular lumen
(Figure 6).
The 200 mg/kg AOGL-treated group shows apparently
intact glomeruli and surrounding Bowman’s space. There is
slight loss of cellular constituents of tubules with no eosino-
philic (colloid) casts in the lumen of the tubules.
The 400 mg/kg AOGL-treated group shows evidence of
apparently intact glomeruli with surrounding Bowman’s
space. There is slight loss of cellular constituents of tubules
Figure 5. Effect of AOGL on TBARS and GSH levels of Wistar rats with gentamicin-induced nephrotoxicity.
*Shows significant difference compared to the control at P < .05. gShows significant difference compared to the toxic control group at P < .05.
Table 3. Effects of Aqueous Extract of Ocimum gratissimum on Creatinine Clearance (mL/min) of Rats With Gentamicin-Induced
Nephrotoxicity.
Control Toxic Toxic Recovery 100 mg/kg AOGL 200 mg/kg AOGL 400 mg/kg AOGL
Creatinine clearance (mL/min)
28 days treatment 53.70 + 13.60 9.07 + 0.50* 1.41 + 0.26*y 0.81 + 1.83*y 0.92 + 0.99*y 0.39 + 0.33*y
14 days recovery 53.70 + 13.60 9.07 + 0.50* 1.41 + 0.26*y 2.03 + 0.52*g 1.68 + 1.55*y 4.99 + 2.51*
Abbreviation: AOGL, aqueous extract of Ocimum gratissimum leaf.
*Shows significant difference compared to the baseline at P < .05.
yShows significant difference compared to the gentamicin treatment at P < .05.
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with no eosinophilic (colloid) casts in the tubular lumen
(Figure 6).
Kidney histological integrity of the 100 mg/kg AOGL-
treated group þ 2-week recovery shows improvement that is
comparable to the control. This is noted by clearly identified
renal corpuscles with the glomeruli surrounded by narrow
Bowman’s space as well as intact capsule epithelia, and intact
proximal convoluted tubule and distal convoluted tubule.
Same is true for 200 mg/kg and 400 mg/kg AOGL-treated
groups þ 2-week recovery, respectively, but with appreciable
improvement in their kidney histoarchitecture when com-
pared with their 100 mg/kg counterpart (Figure 6).
Discussion
The increase in food consumption and body weight that was
associated with gentamicin administration contrasts the studies
of Erdem et al15 and El-Zawahry and Abu El Kheir et al,16 who
reported reductions in food consumption and body weight fol-
lowing gentamicin administration. Physiologic decline in food
intake with aging has been described by Morley.17 He
explained that the expressed early satiation by aged people is
a consequence of increased rate of antral filling as well as
progressive reduction in the adaptive relaxation of the stomach.
Also, there is increased sensitivity to the satiating effects of the
gut hormone “cholecystokinin” with ageing. Therefore, the
different results obtained may be due to age and body
weight–related differences of the rats that were used for the
various studies; while this study engaged body weight of about
150 g, the former involved the use of about 210 to 230 g.16
Also, “fat mass and leptin level” may be a further possible
explanation for the contrasting evidence in food consumption
and body weight. Leptin causes increase in resting metabolic
rate while enhancing decrease in food consumption.18 Both
body leptin level and fat mass increases with ageing.19 Li and
coworkers19 found that in aging male rats, an increase in leptin
gene expression was found to be out of proportion to the
increased adiposity seen with aging. Therefore, the recorded
decrease in food consumption and body weight in previous
studies may not be necessarily due to an apparent anorexic
effect of gentamicin but also on the age and weight of the rats
used.
The further AOGL-induced increase in food consumption
and body weight may be a result of direct stimulation of the
hypothalamic lateral nuclei (feeding center) and/or AOGL-
induced inhibition of the hypothalamic ventromedial nuclei
Figure 6. Photomicrographs showing the effects of AOGL on the kidney histoarchitecture of Wistar rats with gentamicin-induced kidney
injury.
G, glomerulus; P, proximal convoluted tubule; D, distal convoluted tubule; black arrow, Bowman’s space; arrow head, epithelial lining of
Bowman’s capsule; yellow arrow, evidence of tubular cloudy swelling/inflammation; dashed arrow, densely eosinophilic/colloid cast.
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(satiety center) with a consequent increase in food consump-
tion. Also, a study had shown that AOGL administration in rats
caused significant intestinal histological changes, revealing
larger goblet cells as well as increased villi.20 Increased intest-
inal villi facilitate increase in intestinal nutrient absorption due
to increased intestinal surface area.21 Also, acting via inhibition
of muscarinic receptor, AOGL treatment evaluated for antidiar-
rhea effect by inhibiting intestinal motility22 to bring about
increase in intestinal nutrient absorption. These effects of
AOGL on the gastrointestinal tract may be the explanation for
the further increase in food consumption and body weight that
was observed in this study. Nevertheless, this is in contrast with
the report of Ajibade et al,23 who stated that administration of
graded doses of AOGL is associated with a significant decrease
in body weight. The contrasting evidence may be due to dif-
ferences in the doses of AOGL that were administered to the
rats. This study engaged graded doses at 100, 200, and
400 mg/kg/day, while Ajibade et al used 400, 800, 1600, and
3200 mg/kg/day. This implies that relatively higher doses of
AOGL administration may be associated with significant
decrease in body weight. It has been reported that AOGL has
hypoglycemic property,24 an attribute that may have further
contributed to increased food consumption with a conse-
quent increase in body weight. The extract contains flavo-
noids and major mineral elements like calcium, chloride,
manganese, magnesium, zinc, and potassium, which might
also play a contributory role in enhancing its hypoglycemic
property.24 In rats with streptozotocin-induced diabetes,
AOGL administration was found to be associated with a
hypoglycemic effect.25 Hypoglycemia inhibits the satiety
center to bring about increased food consumption by acti-
vating the feeding centre.26
The gentamicin-induced polyuria that was observed in this
study is in agreement with the study of El-Zawahry and Abu
El Kheir.16 However, following AOGL administration, a sig-
nificant increase in water intake was observed without a cor-
responding increase in urine output. This may have resulted
from AOGL-induced increase in plasma osmolarity with a
consequent stimulation of the osmoreceptors that activates the
thirst center in the hypothalamus. Also, the extract may have
stimulated the release of antidiuretic hormone from the
supraoptic nuclei of the hypothalamus to facilitate the water
reabsorption by the distal convoluted tubules with a conse-
quent decrease in urine output. This is, however, subject to
further verifications.
The observed increase in relative kidney weight follow-
ing gentamicin administration may be a result of inflamma-
tory response to the drug-induced injury. This is supported
by the representative photomicrograph, which depicts appar-
ent swelling of the renal tubules. Similar observation was
made by El-Zawahry and Abu El Kheir.16 Nevertheless, in
conformity with the report of Sahouo et al,27 who stated that
AOGL has anti-inflammatory effects on the kidney of rats,
administration of AOGL was associated with a significantly
lowered relative kidney weight when compared with the
control.
An important index of renal function is creatinine determi-
nation.28 Creatinine, a by-product of muscle metabolism and
actively secreted by the proximal tubular cells, is excreted
unchanged by the kidneys. Its level rises in the blood if there
is deficiency in kidney filtration capacity, suggesting remark-
able damage to the nephron. Our findings on creatinine levels
support existing literatures, which showed that gentamicin
toxicity is associated with increased creatinine concentra-
tion.29,30 This was marked with a significant decrease in urine
creatinine, a finding that is consistent with that of El-Zawahry
and Abu El Kheir16 and Parlakpinar et al.31 This further but-
tresses the fact that gentamicin administration has nephrotoxic
potentials.
Creatinine clearance is a measure of excretory function. It is
also an index used to assess renal blood flow. Consequently, a
decrease in creatinine clearance indicates marked reduction in
glomerular filtration rate and renal blood flow. This impair-
ment of glomerular function can result from a rise in renal
vascular resistance and/or damage to the glomerular capillary
endothelium. The gentamicin-induced decrease in creatinine
clearance is indicative of reduced kidney perfusion as well as
a significant tissue injury. This fact was supported by the rep-
resentative photomicrograph, which shows loss of cellular con-
stituents of the tubules. In this study, treatment with AOGL was
accompanied by significant decrease in creatinine clearance, a
report that contrasts the study of Ebeye et al,32 who reported
that administration of the plant extract caused no significant
alteration in the serum levels of some indices of renal function.
This evidence is indicative of the fact that, despite the restora-
tive potential of AOGL on drug-induced kidney injury, pro-
longed administration may be deleterious to the kidney as
evident by the increase in plasma creatinine and reduced crea-
tinine clearance.
Urea, produced by the liver in the urea cycle as a waste
product of metabolism of protein (either from the oxidation of
amino acids or from ammonia), is dissolved into the blood and
transported and excreted by the kidney as a component of
urine. It is a sensitive biomarker used in the assessment of
renal tissue damage. Therefore, in renal tissue injury, there is
retention of urea. Increase urea level is associated with
nephritis, renal ischemia, urinary tract obstruction, and extra-
renal diseases.33 The gentamicin-induced increase in plasma
urea level, as observed in this study, is consistent with the
findings of Pedraza-Chaverrı´ et al29 and Maldonado et al.30 It
has been established that gentamicin causes inhibition of pro-
tein synthesis in renal cells with consequent abundance of
amino acid in the kidney resulting in increased urea levels.2
AOGL administration significantly attenuated the increased
plasma urea levels, a result that is consistent with the findings
of similar study on drug-induced nephrotoxicity.34 The reduc-
tion in plasma urea is suggestive that AOGL activates/
enhances protein synthesis from amino acids, thereby abating
the apparently gentamicin-induced nephritis as depicted by
the representative photomicrograph.
The gentamicin-induced significantly lowered plasma pro-
tein that was accompanied by a significantly increased urine
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total protein may have resulted from damage to the filtration
mechanism of the glomerular basement membrane as well as
reabsorptive failure of the proximal convoluted tubules with
consequent leaking of plasma protein into the urine.35 This
observed change is in accordance with the report of
El-Zawahry and Abu El Kheir,16 who stated that gentamicin
administration to rats is associated with the excretion of pro-
tein. Worthy of note is the fact that apparently healthy rats
express physiologic proteinuria.36-38 Little wonder even the
control group excreted some measure of protein in their urine.
However, AOGL administration significantly reversed the
deleterious alteration of plasma and urine total protein levels.
The decrease in urine total protein is an indication that AOGL
may have potentiated the recovery of the filtration barriers’
integrity from injury that was induced by gentamicin. The
extract may have also enhanced post-glomerular processing
of plasma protein by the renal tubules, a fact supported by the
representative photomicrograph.
Consistent with the study of Chinnapa Reddy et al39 were a
significant increase in TBARS as well as a significant decrease
in GSH level following gentamicin administration. These are
measures of lipid peroxidation and oxidative stress. The group
that was left untreated with AOGL following gentamicin
administration showed significant reversal of the drug-
induced perturbation of the antioxidant system, an effect that
may have been due to the release of reparative and prosurvival
factors from the distal tubular cells.40 Also, consistent with the
findings of Chinnapa Reddy et al39 was a significant reversal of
gentamicin-induced deleterious alteration of the antioxidant
system as evident by the levels of TBARS and GSH. This
demonstrates the antioxidant potential of AOGL.
This study recorded a remarkable self-restorative ability
of the kidney following exposure to gentamicin, a report
that is consistent with existing literatures on self-
regenerating potential of the kidney following injury.40,41
Recent evidence showed that activated renal macrophages
contribute to kidney tissue regeneration through induction of
Wnt-7b, a protein associated with kidney tubule develop-
ment, which initiates renal tubular repair and regeneration
after injury.42 Tubular regeneration also results from the
release of reparative and pro-survival factors from the distal
renal tubular cells43 or repairing process achieved by migra-
tion of polarized mature cells into the damaged region,
reconstituting a functional tubular epithelium.44 This is sup-
ported by the representative photomicrograph, which shows
appreciable improvement of the kidney histoarchitecture
when compared with the toxic group.
As observed in this study, biochemical indices of the AOGL-
treated groups after recovery showed no deleterious aftermath
effect of the extract on the kidney function and histology. This is
well depicted by improved integrity and clearly identified renal
corpuscles, an appreciable improvement that appears to be dose-
dependent, that is, more obvious in the groups that received 400
mg/kg and 200 mg/kg than that of 100 mg/kg.
Based on the results from this study, a note of caution is
recommended in the application of the extract for therapeutic
purpose(s) against drug-induced kidney injury. Also, further
study of the biochemical basis of its therapeutic potentials
(particularly at a molecular level) is expedient in order to prop-
erly elucidate the extract’s mechanism of action.
Conclusion
From the results of this study, it is concluded that the aqueous
extract of Ocimum gratissimum ameliorated gentamicin-
induced kidney injury in rats. The ameliorative effects of Oci-
mum gratissimum is evident by a remarkable restoration of
antioxidant enzymes, total protein, and urea concentration
resulting from an improved renal function.
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